Vancomycin therapeutic drug monitoring: focus on patients with hematological malignancies
Objective This study aimed to identify key factors influencing vancomycin serum concentrations in adult patients with hematological malignancies by analyzing various physiological and biochemical indicators, to assess the impact on vancomycin levels and provide a basis for judicious clinical applica...
Saved in:
| Main Authors: | Yifan Luo, Sihan Liu, Shu Yang, Yang Chu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2496541 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vancomycin Therapeutic Drug Monitoring
by: Bhaskar Shenoy, et al.
Published: (2023-04-01) -
Therapeutic Monitoring of Vancomycin Implemented by Eremomycin ELISA
by: Inna A. Galvidis, et al.
Published: (2024-11-01) -
Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring
by: Wissam K Kabbara, et al.
Published: (2018-11-01) -
Unexpected falsely high vancomycin concentrations in a patient with endocarditis during routine therapeutic drug monitoring
by: Laura Galán-Caballero, et al.
Published: (2025-06-01) -
Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients
by: Mioljević Vesna, et al.
Published: (2013-01-01)